A longterm goal Devloo has is to compete at the Olympics to raise further awareness. His documentary premiers in Hope at the ...

Vertex Pharma's non-opioid painkiller suzetrigine was unable to perform better than placebo in a phase 2 trial in lumbar radiculopathy (LSR), a form of neuropathic back pain, ahead of an FDA ...

Atomi Financial Group Inc. bought a new stake in argenx SE (NASDAQ:ARGX – Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange ...

The following is a summary of “Evidence-Based Umbrella Review of Non-Invasive Neuromodulation in Chronic Neuropathic Pain,” published in the January 2025 issue of Pain by Duarte-Moreira et al.